| Title | A study evaluating the efficacy, safety and tolerability of switching to dolutegravir/lamivudine fixed dose combination in HIV-1 infected adults_clinical study |
|---|---|
| Description | A Phase 3, randomized, multicenter, open-label, non-inferiority study evaluating the efficacy, safety and tolerability of switching to dolutegravir/lamivudine fixed dose combination in HIV-1 infected adults who are virologically suppressed_clinical data for Chinese subjects |
| Organism | Homo sapiens |
| Data Type | Clinical Research data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA013268 |
| Release Date | 2024-12-31 |
| Submitter | Fujie Zhang (treatment@chinaaids.cn) |
| Organization | Beijing Ditan Hospital Affiliated to Capital Medical University |
| Submission Date | 2022-11-16 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX002363-02 | A Phase III, randomized, multicenter, open-label, non-inferiority study evaluating the efficacy, safety and tolerability of switching to dolutegravir/lamivudine fixed dose combination in HIV-1 infected adults who are virologically suppressed_clinical data for Chinese subjects | 3 | Clinical Research data | 226.3 KB | zip | Controlled |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|